Total Payments
$1,095
2024 Payments
$80.55
Companies
14
Transactions
24
Medicare Patients
766
Medicare Billing
$56,195
Payment Breakdown by Category
Education$714.00 (65.2%)
Food & Beverage$380.51 (34.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $714.00 | 1 | 65.2% |
| Food and Beverage | $380.51 | 23 | 34.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pylant Medical | $773.97 | 2 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $106.26 | 8 | $0 (2022) |
| Mylan Specialty L.P. | $37.69 | 2 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $34.81 | 2 | $0 (2017) |
| Stryker Corporation | $21.50 | 1 | $0 (2020) |
| TREACE MEDICAL CONCEPTS, INC. | $20.58 | 1 | $0 (2024) |
| Sanofi Pasteur Inc. | $15.09 | 1 | $0 (2018) |
| Vanda Pharmaceuticals Inc. | $13.89 | 1 | $0 (2018) |
| Janssen Scientific Affairs, LLC | $13.33 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12.34 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $80.55 | 2 | Pylant Medical ($59.97) |
| 2022 | $109.82 | 8 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($94.63) |
| 2021 | $10.10 | 1 | Organon LLC ($10.10) |
| 2020 | $55.63 | 3 | Mylan Specialty L.P. ($22.50) |
| 2019 | $11.25 | 1 | Amgen Inc. ($11.25) |
| 2018 | $54.55 | 4 | Sanofi Pasteur Inc. ($15.09) |
| 2017 | $772.61 | 5 | Pylant Medical ($714.00) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2024 | Pylant Medical | — | Food and Beverage | In-kind items and services | $59.97 | General |
| 04/25/2024 | TREACE MEDICAL CONCEPTS, INC. | LAPIPLASTY SYSTEM (Device) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: FOOT AND ANKLE | ||||||
| 12/21/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Gastroenterology | ||||||
| 12/21/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Gastroenterology | ||||||
| 10/26/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Gastroenterology | ||||||
| 08/10/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Gastroenterology | ||||||
| 06/22/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Gastroenterology | ||||||
| 05/03/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/30/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Gastroenterology | ||||||
| 03/09/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Gastroenterology | ||||||
| 11/19/2021 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: CONTRACEPTIVES | ||||||
| 12/30/2020 | Stryker Corporation | TRIATHLON (Device) | Food and Beverage | Cash or cash equivalent | $21.50 | General |
| Category: KNEES | ||||||
| 09/15/2020 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Respiratory and Allergy | ||||||
| 08/17/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/19/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Neuroscience | ||||||
| 08/02/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.24 | General |
| 07/12/2018 | Janssen Scientific Affairs, LLC | PREZCOBIX (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 04/20/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug), FLUZONE QUADRIVALENT | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: VACCINES | ||||||
| 01/18/2018 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Schizophrenia | ||||||
| 12/14/2017 | INSYS Therapeutics Inc | SUBSYS (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: Breakthrough Cancer Pain | ||||||
| 11/27/2017 | Pylant Medical | — | Education | In-kind items and services | $714.00 | General |
| 11/09/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: RESPIRATORY | ||||||
| 07/14/2017 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: NEUROSCIENCE | ||||||
| 02/03/2017 | Merck Sharp & Dohme Corporation | ASMANEX (Drug), BELSOMRA, DULERA | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 152 | 432 | $23,279 | $11,557 |
| 2022 | 5 | 173 | 407 | $28,311 | $14,542 |
| 2021 | 5 | 189 | 464 | $28,610 | $14,464 |
| 2020 | 5 | 252 | 658 | $34,140 | $15,632 |
Total Patients
766
Total Services
1,961
Medicare Billing
$56,195
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 93 | $14,276 | $7,759 | 54.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 36 | $3,744 | $1,937 | 51.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 30 | 39 | $3,939 | $1,665 | 42.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 41 | 264 | $1,320 | $195.50 | 14.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 74 | $11,359 | $6,714 | 59.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 75 | $8,306 | $4,774 | 57.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 25 | 44 | $4,516 | $1,945 | 43.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $2,912 | $938.96 | 32.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 29 | 199 | $1,218 | $168.94 | 13.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 48 | 60 | $9,277 | $5,688 | 61.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 67 | $7,934 | $4,249 | 53.5% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 35 | 62 | $6,262 | $2,884 | 46.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 17 | 17 | $3,736 | $1,396 | 37.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 37 | 258 | $1,401 | $246.51 | 17.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 92 | 156 | $16,320 | $8,161 | 50.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 41 | 43 | $6,601 | $3,322 | 50.3% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 44 | 67 | $7,372 | $3,169 | 43.0% |
| 20550 | Injections of tendon sheath, ligament, or muscle membrane | Office | 2020 | 16 | 17 | $1,853 | $573.94 | 31.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 59 | 375 | $1,995 | $406.09 | 20.4% |
About Dr. Vikrant Landge, MD
Dr. Vikrant Landge, MD is a Orthopaedic Surgery healthcare provider based in Stilwell, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2011. The National Provider Identifier (NPI) number assigned to this provider is 1649554593.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vikrant Landge, MD has received a total of $1,095 in payments from pharmaceutical and medical device companies, with $80.55 received in 2024. These payments were reported across 24 transactions from 14 companies. The most common payment nature is "Education" ($714.00).
As a Medicare-enrolled provider, Landge has provided services to 766 Medicare beneficiaries, totaling 1,961 services with total Medicare billing of $56,195. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Orthopaedic Surgery
- Other Specialties Orthopaedic Surgery, Orthopaedic Surgery
- Location Stilwell, OK
- Active Since 10/10/2011
- Last Updated 10/14/2015
- Taxonomy Code 207X00000X
- Entity Type Individual
- NPI Number 1649554593
Products in Payments
- XIFAXAN (Drug) $106.26
- Yupelri (Drug) $37.69
- TRIATHLON (Device) $21.50
- LAPIPLASTY SYSTEM (Device) $20.58
- ASMANEX (Drug) $18.06
- BELSOMRA (Drug) $16.75
- FLUZONE HIGH-DOSE (Drug) $15.09
- Fanapt (Drug) $13.89
- PREZCOBIX (Drug) $13.33
- SPIRIVA (Drug) $12.34
- SUBSYS (Drug) $11.46
- Aimovig (Biological) $11.25
- NEXPLANON (Drug) $10.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.